• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于细胞内自组装的不间断活性氧发生器增强了基于 5-氨基酮戊酸的肿瘤治疗。

An Intracellular Self-Assembly-Driven Uninterrupted ROS Generator Augments 5-Aminolevulinic-Acid-Based Tumor Therapy.

机构信息

School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, China.

Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou, Henan Province, 450001, China.

出版信息

Adv Mater. 2022 Jul;34(30):e2201049. doi: 10.1002/adma.202201049. Epub 2022 Jun 20.

DOI:10.1002/adma.202201049
PMID:35488781
Abstract

Free radical therapy based on 5-aminolevulinic acid (ALA, a precursor of the photosensitizer protoporphyrin IX (PpIX)) has been approved by the US Food and Drug Administration for clinical tumor treatment. However, PpIX can be quickly converted into photoinactive heme, leading to unexpectedly paused production of free radicals and severely hindering its therapeutic benefits. Here, inspired by the natural biotransformation of ALA (ALA-PpIX-heme), an uninterrupted reactive oxygen species generator (URG) that converts useless heme to peroxidase mimics via intracellular self-assembly is developed. The URG is prepared by enwrapping ALA-loaded polyamide-amine dendrimers in red blood cell membrane vesicles with a further surface modification of G-quadruplex-structured AS1411. The URGs realize " O -•OH" uninterrupted generation through "recycling waste" in two steps: i) PpIX generates O under laser irradiation; and ii) the photoinactive metabolite heme self-assembled with AS1411 to catalyze H O conversion into •OH. Interestingly, the specific generation of O in mitochondria and •OH in nuclei further augments the free-radical-induced damage. It is demonstrated that URG can continuously produce free radicals for 6 h postirradiation, and shows 3.3-times more than that of the nonassembly group, achieving nearly 80% regression of tumors in vivo.

摘要

基于 5-氨基酮戊酸(ALA,一种原卟啉 IX(PpIX)的光敏剂前体)的自由基疗法已被美国食品和药物管理局批准用于临床肿瘤治疗。然而,PpIX 可以迅速转化为非光活性的血红素,导致自由基的产生意外暂停,严重阻碍了其治疗效果。在这里,受 ALA(ALA-PpIX-血红素)的自然生物转化的启发,开发了一种不间断的活性氧物种发生器(URG),它通过细胞内自组装将无用的血红素转化为过氧化物酶模拟物。URG 通过用 G-四链体结构 AS1411 进一步表面修饰将负载 ALA 的聚酰胺-胺树枝状大分子包裹在红细胞膜囊泡中制备。URGs 通过两步“回收废物”实现“ O -•OH”的不间断生成:i)激光照射下 PpIX 生成 O ;ii)与 AS1411 自组装的非光活性代谢物血红素催化 H O 转化为•OH。有趣的是,线粒体中 O 的特异性生成和核中•OH 的特异性生成进一步增强了自由基诱导的损伤。结果表明,URG 可以在辐照后持续 6 小时产生自由基,比非组装组多产生 3.3 倍,在体内实现近 80%的肿瘤消退。

相似文献

1
An Intracellular Self-Assembly-Driven Uninterrupted ROS Generator Augments 5-Aminolevulinic-Acid-Based Tumor Therapy.一种基于细胞内自组装的不间断活性氧发生器增强了基于 5-氨基酮戊酸的肿瘤治疗。
Adv Mater. 2022 Jul;34(30):e2201049. doi: 10.1002/adma.202201049. Epub 2022 Jun 20.
2
Regulating Photosensitizer Metabolism with DNAzyme-Loaded Nanoparticles for Amplified Mitochondria-Targeting Photodynamic Immunotherapy.用负载 DNAzyme 的纳米颗粒调节光敏剂代谢,用于放大的线粒体靶向光动力免疫治疗。
ACS Nano. 2023 Jul 25;17(14):13746-13759. doi: 10.1021/acsnano.3c03308. Epub 2023 Jul 12.
3
Effect of 5-aminolevulinic acid-based photodynamic therapy via reactive oxygen species in human cholangiocarcinoma cells.基于活性氧的 5-氨基酮戊酸光动力疗法对人胆管癌细胞的影响。
Int J Nanomedicine. 2011;6:1357-63. doi: 10.2147/IJN.S21395. Epub 2011 Jun 30.
4
5-Aminolevulinic acid strongly enhances delayed intracellular production of reactive oxygen species (ROS) generated by ionizing irradiation: quantitative analyses and visualization of intracellular ROS production in glioma cells in vitro.5-氨基乙酰丙酸强烈增强电离辐射产生的活性氧(ROS)的延迟细胞内生成:体外胶质瘤细胞内ROS生成的定量分析与可视化
Oncol Rep. 2015 Feb;33(2):583-90. doi: 10.3892/or.2014.3618. Epub 2014 Nov 24.
5
Prodrug-based strategy with a two-in-one liposome for Cerenkov-induced photodynamic therapy and chemotherapy.基于前药的两亲脂质体策略用于契伦科夫光动力学治疗和化学疗法。
J Control Release. 2023 Dec;364:206-215. doi: 10.1016/j.jconrel.2023.10.036. Epub 2023 Oct 31.
6
5-Aminolevulinic Acid-Induced Protoporphyrin IX Fluorescence Imaging for Tumor Detection: Recent Advances and Challenges.5-氨基酮戊酸诱导原卟啉 IX 荧光成像用于肿瘤检测:最新进展与挑战。
Int J Mol Sci. 2022 Jun 9;23(12):6478. doi: 10.3390/ijms23126478.
7
Modulation and proteomic changes on the heme pathway following treatment with 5-aminolevulinic acid.ALA 处理后血红素途径的调节和蛋白质组变化。
J Photochem Photobiol B. 2022 Aug;233:112484. doi: 10.1016/j.jphotobiol.2022.112484. Epub 2022 May 30.
8
Aminolevulinic Acid-Based Tumor Detection and Therapy: Molecular Mechanisms and Strategies for Enhancement.基于氨基乙酰丙酸的肿瘤检测与治疗:分子机制及增强策略
Int J Mol Sci. 2015 Oct 28;16(10):25865-80. doi: 10.3390/ijms161025865.
9
Kinetic Evaluation of Determinant Factors for Cellular Accumulation of Protoporphyrin IX Induced by External 5-Aminolevulinic Acid for Photodynamic Cancer Therapy.用于光动力癌症治疗的外源性5-氨基乙酰丙酸诱导细胞内原卟啉IX蓄积的决定因素的动力学评估
J Pharm Sci. 2015 Sep;104(9):3092-100. doi: 10.1002/jps.24462. Epub 2015 May 8.
10
Comparison of 5-aminolevulinic acid and its hexylester mediated photodynamic action on human hepatoma cells.5-氨基乙酰丙酸及其己酯介导的光动力作用对人肝癌细胞的比较。
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2002 Sep;34(5):650-4.

引用本文的文献

1
Exploring the role of LOX family in glioma progression and immune modulation.探索赖氨酰氧化酶(LOX)家族在神经胶质瘤进展和免疫调节中的作用。
Front Immunol. 2025 Apr 9;16:1512186. doi: 10.3389/fimmu.2025.1512186. eCollection 2025.
2
Innovative utilization of cell membrane-coated nanoparticles in precision cancer therapy.细胞膜包被纳米颗粒在精准癌症治疗中的创新应用。
Exploration (Beijing). 2024 Mar 21;4(6):20230164. doi: 10.1002/EXP.20230164. eCollection 2024 Dec.
3
Engineered cyanobacteria-FeO hybrid system as oxygen generator and photosensitizer production factory for synergistic cancer PDT-immunotherapy.
工程化蓝藻-氧化铁混合系统作为用于协同癌症光动力疗法-免疫疗法的氧气发生器和光敏剂生产工厂。
Mater Today Bio. 2024 Aug 8;28:101192. doi: 10.1016/j.mtbio.2024.101192. eCollection 2024 Oct.
4
Iron metabolism: backfire of cancer cell stemness and therapeutic modalities.铁代谢:癌细胞干性的反作用及治疗方式
Cancer Cell Int. 2024 May 4;24(1):157. doi: 10.1186/s12935-024-03329-x.
5
Towards overcoming obstacles of type II photodynamic therapy: Endogenous production of light, photosensitizer, and oxygen.迈向克服II型光动力疗法的障碍:光、光敏剂和氧气的内源性产生。
Acta Pharm Sin B. 2024 Mar;14(3):1111-1131. doi: 10.1016/j.apsb.2023.11.007. Epub 2023 Nov 4.
6
Application of G-quadruplex targets in gastrointestinal cancers: Advancements, challenges and prospects.G-四链体靶点在胃肠道癌症中的应用:进展、挑战与前景
World J Gastrointest Oncol. 2023 Jul 15;15(7):1149-1173. doi: 10.4251/wjgo.v15.i7.1149.
7
Light-responsive nanomedicine for cancer immunotherapy.用于癌症免疫治疗的光响应纳米药物。
Acta Pharm Sin B. 2023 Jun;13(6):2346-2368. doi: 10.1016/j.apsb.2023.05.016. Epub 2023 May 19.
8
Self-actuated biomimetic nanocomposites for photothermal therapy and PD-L1 immunosuppression.用于光热疗法和PD-L1免疫抑制的自驱动仿生纳米复合材料。
Front Chem. 2023 Mar 17;11:1167586. doi: 10.3389/fchem.2023.1167586. eCollection 2023.
9
Continuous Spatiotemporal Therapy of A Full-API Nanodrug via Multi-Step Tandem Endogenous Biosynthesis.通过多步串联内源性生物合成对全 API 纳米药物进行连续时空治疗。
Nat Commun. 2023 Mar 25;14(1):1660. doi: 10.1038/s41467-023-37315-0.
10
Nanoparticles-based phototherapy systems for cancer treatment: Current status and clinical potential.用于癌症治疗的基于纳米颗粒的光疗系统:现状与临床潜力
Bioact Mater. 2022 Dec 5;23:471-507. doi: 10.1016/j.bioactmat.2022.11.013. eCollection 2023 May.